Reviewed,
UniProtKB/Swiss-Prot P11245 (ARY2_HUMAN)
Last modified
November 25, 2008.
Version 91.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Arylamine N-acetyltransferase 2 EC=2.3.1.5 Alternative name(s): Arylamide acetylase 2 Polymorphic arylamine N-acetyltransferase Short name=PNAT N-acetyltransferase type 2 Short name=NAT-2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 290 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. |
| Catalytic activity | Acetyl-CoA + an arylamine = CoA + an N-acetylarylamine. |
| Subcellular location | |
| Involvement in disease | Genetic variations in NAT2 determine N-acetylation polymorphism by a low or high NAT activity in the liver [MIM:243400]. It has been implicated in the action and toxicity of amine-containing drugs, and in the susceptibility to bladder cancer and systemic lupus erythematosus. This isozyme is responsible for this polymorphism. |
| Sequence similarities | Belongs to the arylamine N-acetyltransferase family. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Cytoplasm |
| Coding sequence diversity | Polymorphism |
| Molecular function | Acyltransferase Transferase |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | metabolic process Inferred from electronic annotation. Source: InterPro |
| Cellular component | cytosol Inferred from Experiment. Source: Reactome |
| Molecular function | arylamine N-acetyltransferase activity Ref.2 Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 290 | 290 | Arylamine N-acetyltransferase 2 | PRO_0000107905 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 68 | 1 | Acyl-thioester intermediate By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 107 | 1 | By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 122 | 1 | By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 246 | 1 | Phosphotyrosine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 24 | 1 | L → I: dbSNP rs45477599. | VAR_018853 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 64 | 1 | R → Q in allele NAT2*14A, allele NAT2*14B, allele NAT2*14C, allele NAT2*14D, allele NAT2*14E, allele NAT2*14F and allele NAT2*14G; a slow acetylator. dbSNP rs1801279. | VAR_004608 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 64 | 1 | R → W in allele NAT2*19. dbSNP rs1805158. | VAR_009075 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 114 | 1 | I → T in allele NAT2*5A, allele NAT2*5B, allele NAT2*5C, allele NAT2*5D, allele NAT2*5E, allele NAT2*5F, allele NAT2*14B and allele NAT2*14E; a slow acetylator. dbSNP rs1801280. | VAR_004609 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 122 | 1 | D → N: dbSNP rs4986996. | VAR_020385 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 135 | 1 | L → V: dbSNP rs12720065. | VAR_046905 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 137 | 1 | L → F: dbSNP rs4986997. | VAR_020386 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 145 | 1 | Q → P in allele NAT2*17. | VAR_009076 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 193 | 1 | T → M | VAR_028781 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 197 | 1 | R → Q in allele NAT2*5E, allele NAT2*6A, allele NAT2*6B, allele NAT2*6C, allele NAT2*6D and allele NAT2*14D; a slow acetylator. dbSNP rs1799930. | VAR_004610 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 208 | 1 | Y → H: dbSNP rs56387565. | VAR_028782 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 228 | 1 | P → L: dbSNP rs45518335. | VAR_018854 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 268 | 1 | K → R in allele NAT2*5B, allele NAT2*5C, allele NAT2*5F, allele NAT2*6C, allele NAT2*12A, allele NAT2*14B, allele NAT2*14C, allele NAT2*14E, allele NAT2*14F and allele NAT2*14G. dbSNP rs1208. | VAR_004611 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 282 | 1 | K → T in allele NAT2*18. dbSNP rs56054745. | VAR_009077 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 286 | 1 | G → E in allele NAT2*7A and allele NAT2*7B; a slow acetylator. dbSNP rs1799931. | VAR_004612 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 6 | 1 | Y → D in CAG28559. Ref.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 30 | 1 | H → T AA sequence Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 286 | 1 | G → R Ref.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 2 – 9 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 21 – 34 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 40 – 43 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 52 – 59 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 68 – 82 | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 85 – 95 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 96 – 98 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 107 – 114 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 117 – 121 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 127 – 129 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 144 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 149 – 155 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 158 – 164 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 167 – 171 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 173 – 175 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 185 – 192 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 199 – 202 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 203 – 211 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 216 – 219 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 222 – 226 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 228 – 235 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 238 – 247 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 250 – 257 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 260 – 269 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 285 – 288 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylation." Grant D.M., Blum M., Demierre A., Meyer U.A. Nucleic Acids Res. 17:3978-3978(1989) [PubMed: 2734109] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression." Blum M., Grant D.M., McBride W., Heim M., Meyer U.A. DNA Cell Biol. 9:193-203(1990) [PubMed: 2340091] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver." Ohsako S., Deguchi T. J. Biol. Chem. 265:4630-4634(1990) [PubMed: 1968463] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT GLU-286. Tissue: Liver. |
| [4] | "Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver." Deguchi T. J. Biol. Chem. 267:18140-18147(1992) [PubMed: 1381364] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (NAT2*6D), VARIANTS GLN-197 AND GLU-286. Tissue: Liver. |
| [5] | "Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles." Ferguson R.J., Doll M.A., Rustan T.D., Gray K., Hein D.W. Drug Metab. Dispos. 22:371-376(1994) [PubMed: 7915226] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (NAT2*5C AND NAT2*14), VARIANTS GLN-64; THR-114 AND ARG-268. |
| [6] | "Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes." Patin E., Barreiro L.B., Sabeti P.C., Austerlitz F., Luca F., Sajantila A., Behar D.M., Semino O., Sakuntabhai A., Guiso N., Gicquel B., McElreavey K., Harding R.M., Heyer E., Quintana-Murci L. Am. J. Hum. Genet. 78:423-436(2006) [PubMed: 16416399] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ILE-24; GLN-64; THR-114; MET-193; GLN-197; HIS-208; ARG-268 AND GLU-286. |
| [7] | Doll M.A., Satran S.L., Hein D.W. Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (NAT2*12A), VARIANT ARG-268. |
| [8] | Leff M.A., Doll M.A., Feng Y., Fretland A.J., Hein D.W. Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (NAT2*5D; NAT2*6D; NAT2*14G), VARIANTS GLN-64; THR-114; GLN-197 AND ARG-268. |
| [9] | "A novel linkage of two NAT2 mutations." Banerjee M., Anitha A. Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-114. |
| [10] | "A novel allele showing linkage with 282, 341, 481, 803 point mutaions in the NAT2 gene." Pillai A.A., Banerjee M. Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS THR-114 AND ARG-268. |
| [11] | "A novel NAT2 allele with point mutations 341, 481, 803, 859 in the ethnic populations of Kerala." Pillai A.A., Banerjee M. Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS THR-114 AND ARG-268. |
| [12] | Doll M.A., Zang Y., Yeager M., Welch R., Chanock S., Hein D.W. Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS THR-114; ASN-122; PHE-137 AND ARG-268. |
| [13] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [14] | "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)." Rieder M.J., Livingston R.J., Daniels M.R., Montoya M.A., Chung M.-W., Miyamoto K.E., Nguyen C.P., Nguyen D.A., Poel C.L., Robertson P.D., Schackwitz W.S., Sherwood J.K., Witrak L.A., Nickerson D.A. Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ILE-24; GLN-64; THR-114; GLN-197; LEU-228; ARG-268 AND GLU-286. |
| [15] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT GLN-197. Tissue: Liver. |
| [16] | "Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases." Ebisawa T., Deguchi T. Biochem. Biophys. Res. Commun. 177:1252-1257(1991) [PubMed: 1676262] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22. |
| [17] | "Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver." Grant D.M., Lottspeich F., Meyer U.A. FEBS Lett. 244:203-207(1989) [PubMed: 2924904] [Abstract] Cited for: PROTEIN SEQUENCE OF 18-33 AND 189-197. |
| [18] | "Diverse point mutations in the human gene for polymorphic N-acetyltransferase." Vatsis K.P., Martell K.J., Weber W.W. Proc. Natl. Acad. Sci. U.S.A. 88:6333-6337(1991) [PubMed: 2068113] [Abstract] Cited for: VARIANTS. |
| [19] | "The structure and characteristics of a fourth allele of polymorphic N-acetyltransferase gene found in the Japanese population." Abe M., Deguchi T., Suzuki T. Biochem. Biophys. Res. Commun. 191:811-816(1993) [PubMed: 8466518] [Abstract] Cited for: VARIANTS. |
| [20] | "Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene." Lin H.J., Han C.Y., Lin B.K., Hardy S. Pharmacogenetics 4:125-134(1994) [PubMed: 7920692] [Abstract] Cited for: VARIANTS NAT2*17 PRO-145 AND NAT2*18 THR-282. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| X14672 Genomic DNA. Translation: CAA32802.1. D90040 mRNA. Translation: BAA14094.1. D90042 mRNA. Translation: BAA14096.1. D10870 Genomic DNA. Translation: BAA01640.1. D10871 Genomic DNA. Translation: BAA01641.1. D10872 Genomic DNA. Translation: BAA01642.1. U23052 Genomic DNA. Translation: AAA64584.1. U23434 Genomic DNA. Translation: AAA64585.1. DQ305496 Genomic DNA. Translation: ABC26032.1. DQ305497 Genomic DNA. Translation: ABC26033.1. DQ305498 Genomic DNA. Translation: ABC26034.1. DQ305499 Genomic DNA. Translation: ABC26035.1. DQ305500 Genomic DNA. Translation: ABC26036.1. DQ305501 Genomic DNA. Translation: ABC26037.1. DQ305502 Genomic DNA. Translation: ABC26038.1. DQ305503 Genomic DNA. Translation: ABC26039.1. DQ305504 Genomic DNA. Translation: ABC26040.1. DQ305505 Genomic DNA. Translation: ABC26041.1. DQ305506 Genomic DNA. Translation: ABC26042.1. DQ305507 Genomic DNA. Translation: ABC26043.1. DQ305508 Genomic DNA. Translation: ABC26044.1. DQ305509 Genomic DNA. Translation: ABC26045.1. DQ305510 Genomic DNA. Translation: ABC26046.1. DQ305511 Genomic DNA. Translation: ABC26047.1. DQ305512 Genomic DNA. Translation: ABC26048.1. DQ305513 Genomic DNA. Translation: ABC26049.1. DQ305514 Genomic DNA. Translation: ABC26050.1. DQ305515 Genomic DNA. Translation: ABC26051.1. DQ305516 Genomic DNA. Translation: ABC26052.1. DQ305517 Genomic DNA. Translation: ABC26053.1. DQ305518 Genomic DNA. Translation: ABC26054.1. DQ305519 Genomic DNA. Translation: ABC26055.1. DQ305520 Genomic DNA. Translation: ABC26056.1. DQ305521 Genomic DNA. Translation: ABC26057.1. DQ305522 Genomic DNA. Translation: ABC26058.1. DQ305523 Genomic DNA. Translation: ABC26059.1. DQ305524 Genomic DNA. Translation: ABC26060.1. DQ305525 Genomic DNA. Translation: ABC26061.1. DQ305526 Genomic DNA. Translation: ABC26062.1. DQ305527 Genomic DNA. Translation: ABC26063.1. DQ305528 Genomic DNA. Translation: ABC26064.1. DQ305529 Genomic DNA. Translation: ABC26065.1. DQ305530 Genomic DNA. Translation: ABC26066.1. DQ305531 Genomic DNA. Translation: ABC26067.1. DQ305532 Genomic DNA. Translation: ABC26068.1. DQ305533 Genomic DNA. Translation: ABC26069.1. DQ305534 Genomic DNA. Translation: ABC26070.1. DQ305535 Genomic DNA. Translation: ABC26071.1. DQ305536 Genomic DNA. Translation: ABC26072.1. DQ305537 Genomic DNA. Translation: ABC26073.1. DQ305538 Genomic DNA. Translation: ABC26074.1. DQ305539 Genomic DNA. Translation: ABC26075.1. DQ305540 Genomic DNA. Translation: ABC26076.1. DQ305541 Genomic DNA. Translation: ABC26077.1. DQ305542 Genomic DNA. Translation: ABC26078.1. DQ305543 Genomic DNA. Translation: ABC26079.1. DQ305544 Genomic DNA. Translation: ABC26080.1. DQ305545 Genomic DNA. Translation: ABC26081.1. DQ305546 Genomic DNA. Translation: ABC26082.1. DQ305547 Genomic DNA. Translation: ABC26083.1. DQ305548 Genomic DNA. Translation: ABC26084.1. DQ305549 Genomic DNA. Translation: ABC26085.1. DQ305550 Genomic DNA. Translation: ABC26086.1. DQ305551 Genomic DNA. Translation: ABC26087.1. DQ305552 Genomic DNA. Translation: ABC26088.1. | |

Clusters with